Pfizer moves forward with once-daily version of weight loss pill after setbacks

[cafead]

via

• Pfizer said it will continue to develop the once-daily version of its weight loss pill, danuglipron, after it saw “encouraging” data in an early-stage trial.
• The company plans to conduct studies in the second half of the year evaluating multiple doses of the drug.

article source